XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
XORTX Therapeutics Inc. (XRTX)
Company Research
Source: GlobeNewswire
CALGARY, Alberta, March 05, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce that it has filed its notice of meeting, management information circular (the “Circular”) and related documents (collectively, the “Meeting Materials”) with securities regulators in connection with its upcoming Annual and Special Meeting (the “Meeting”) of holders of common shares (“Shareholders”). The Meeting Materials have also been mailed to Shareholders and can be accessed online on XORTX’s website at this link, under the Company’s SEDAR+ profile (www.sedarplus.ca) and the SEC’s website (www.sec.gov). The mailing of the Circular and related Meeting materials occurred on March 2, 2026. Meeting Details The Meeting will be held on March 24, 2026 at 10:00 am (Calgary Time) at th
Show less
Read more
Impact Snapshot
Event Time:
XRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XRTX alerts
High impacting XORTX Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
XRTX
News
- XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of ShareholdersGlobeNewswire
- XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation [Yahoo! Finance]Yahoo! Finance
- XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share ConsolidationGlobeNewswire
- XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus BiosystemsGlobeNewswire
- XORTX Therapeutics Says Published Research Supports Company Approach to Gout Treatment [Yahoo! Finance]Yahoo! Finance
XRTX
Sec Filings
- 3/20/26 - Form 20-F
- 3/19/26 - Form 6-K
- 3/13/26 - Form 6-K
- XRTX's page on the SEC website